Klinger joined the Cambridge, Massachusetts-based pharmaceutical company in 2021, when Moderna's stock was trading at around ...
3hon MSN
Under normal circumstances, the study of health problems after COVID vaccinations posted online on Feb. 25 might not have ...
Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...
Pfizer and BioNTech won a round in their legal battle with Moderna over COVID-19 vaccine patents on Wednesday, convincing a U ...
Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...
23hon MSN
Another recent federal study, published in the journal JAMA Pediatrics in February, showed approximately 1.01 million ...
The door may now be open for additional challenges to patents covering mRNA vaccine technologies, paving the way for increased competition in the ...
The Düsseldorf Regional Court has ordered Pfizer and its German partner BioNTech to pay damages for the use of Moderna’s ...
The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results